Rajcsanyi Luisa Sophie, Kesselmeier Miriam, Schröder Christopher, Schmelting Carolin, Peters Triinu, Föcker Manuel, Kraft Isabelle, Beygo Jasmin, Leitão Elsa, Zeschnigk Michael, Giuranna Johanna, Herpertz-Dahlmann Beate, Seitz Jochen, de Zwaan Martina, Herzog Wolfgang, Ehrlich Stefan, Zipfel Stephan, Giel Katrin, Egberts Karin, Burghardt Roland, Budeus Bettina, Hebebrand Johannes, Horsthemke Bernhard, Hinney Anke
Section of Molecular Genetics in Mental Disorders, University Hospital Essen, University of Duisburg-Essen, Virchowstr 174, 45147, Essen, Germany.
Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Sci Rep. 2025 Aug 7;15(1):28870. doi: 10.1038/s41598-025-12592-5.
Anorexia nervosa (AN) is a mental disorder marked by a significantly low body weight. Differentially methylated CpG sites have been reported to be involved in body weight regulation. Methylation pattern may change during considerable weight gain by in-patient treatment. Consequently, we aimed to (1) replicate the hypomethylation at the NR1H3 gene locus (identified in our previous epigenome-wide association study) in independent study groups of 189 female patients with AN and 67 healthy-lean female controls, and (2) identify regions associated with large weight gain associated DNA methylation changes in three patients with AN through whole-genome bisulfite sequencing in CD14 cells. In the replication study, no evidence was observed for hypomethylation at the investigated 15 CpG sites of the NR1H3 locus. Relying on two analysis tools (camel, metilene) to identify differentially methylated regions (DMRs), subtle methylation differences concordant between both tools were detected only when the usual threshold of camel was lowered. Then, eight regions were selected exemplarily for technical replication with deep bisulfite sequencing in the same three patients with AN. None of the regions could be confirmed. Summarising, we could not confirm hypomethylation at NR1H3 and could not detect methylation differences in patients with AN between admission and weight gain at discharge.
神经性厌食症(AN)是一种以体重显著偏低为特征的精神障碍。据报道,差异甲基化的CpG位点参与体重调节。住院治疗导致体重显著增加期间,甲基化模式可能会发生变化。因此,我们旨在:(1)在189名女性AN患者和67名健康瘦女性对照的独立研究组中,重复在我们之前的全表观基因组关联研究中确定的NR1H3基因座的低甲基化;(2)通过对CD14细胞进行全基因组亚硫酸氢盐测序,在三名AN患者中识别与体重大幅增加相关的DNA甲基化变化区域。在重复研究中,未观察到NR1H3基因座的15个CpG位点存在低甲基化的证据。依靠两种分析工具(camel、metilene)来识别差异甲基化区域(DMR),只有当camel的常规阈值降低时,才检测到两种工具之间一致的细微甲基化差异。然后,示例性地选择八个区域,在同三名AN患者中进行深度亚硫酸氢盐测序技术重复。没有一个区域得到证实。总之,我们无法证实NR1H3存在低甲基化,也无法检测出AN患者入院时和出院体重增加时的甲基化差异。